Natco Pharma Cash Flow Annual

Trade
BSE: 524816 | NSE: NATCOPHARM | ISIN: INE987B01026 | Sector: Biotechnology & Drugs
1,369.20 +13.20 (0.97%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line 1,673.50861.90202.20579.60
Depreciation/ Depletion 186.80163.80142.60116.90
Non- Cash Items -53.00-61.80-18.70-54.80
Changesin Working Capital -595.70-114.80-279.60-342.90
Cashfrom Operating Activities 1,211.60849.1046.50298.80
Capital Expenditures -339.40-146.30-232.80-254.60
Other Investing Cash Flow Items Total -693.30-330.80227.50151.30
Cashfrom Investing Activities -1,032.70-477.10-5.30-103.30
Financing Cash Flow Items -18.10-14.20-18.80-22.30
Total Cash Dividends Paid -170.80-100.40-82.20-113.90
Issuance( Retirement)of Stock Net -253.70-7.40-0.10
Issuance( Retirement)of Debt Net 195.70-241.00135.80-49.60
Cashfrom Financing Activities -246.90-363.0034.80-185.70
Foreign Exchange Effects 6.5011.809.30-3.80
Net Changein Cash -61.5020.8085.306.00
Cash Interest Paid 18.1014.2017.0012.80
Cash Taxes Paid 286.30177.5048.20130.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts